We serve Chemical Name:erythro-.β.-Hydroxy-DL-aspartic acid CAS:6532-76-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:erythro-.β.-Hydroxy-DL-aspartic acid
CAS.NO:6532-76-9
Synonyms:(2S,3R)-2-amino-3-hydroxy-succinic acid;erythro-3-hydroxy-DL-aspartic acid;(2S,3S)-2-amino-3-hydroxysuccimid acid;2-(S)-amino-3-(S)-hydroxysuccinic acid
Molecular Formula:C4H7NO5
Molecular Weight:149.10200
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:368.7ºC at 760 mmHg
Density:1.738g/cm3
Index of Refraction:1.583
PSA:120.85000
Exact Mass:149.03200
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (2S,3R)-2-amino-3-hydroxy-succinic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(S)-amino-3-(S)-hydroxysuccinic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2S,3R)-2-amino-3-hydroxy-succinic acid Use and application,erythro-3-hydroxy-DL-aspartic acid technical grade,usp/ep/jp grade.
Related News: “The approval of Verquvo in the EU will provide doctors, health care professionals and patients with an important treatment option to complement currently available heart failure therapies,” he added. [PtBr(trimethylphosphine)3]NO3 manufacturers The Ballina facility was first established in 1974 and was acquired by Charles River in 2002. Over the years it has added to its capabilities offering a comprehensive package of GMP services in support of recombinant biologics, vaccines, cell and gene therapies, biosimilars, and medical devices. Charles River now employs 230 people at two facilities in Ireland: the site in Ballina Co. Mayo which focuses on biologics testing, and a site in Dublin, established in 2017, which serves as the EMEA and APAC headquarters for the Company’s Microbial Solutions division. 4-(4,4,5-trimethyl-1,3-diphenyl-4,5-dihydro-1H-pyrazol-5-yl)benzenesulfonamide suppliers Both were randomised, double-blinded, placebo-controlled trials in patients with moderate to severe autoantibody-positive SLE who were receiving standard therapy. 3-(2-Benzhydryloxy-ethyl)-1-ethyl-octahydro-indole vendor & factory.
